Unlock stock picks and a broker-level newsfeed that powers Wall Street.
17.95
-0.75
(-4.01%)
At close: April 4 at 5:26:31 PM GMT+2
Loading Chart for PB8.MU
- Previous Close
18.70 - Open
18.10 - Bid 17.40 x --
- Ask 17.70 x --
- Day's Range
17.95 - 18.10 - 52 Week Range
11.40 - 25.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: PB8.MU
View MorePerformance Overview: PB8.MU
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
PB8.MU
8.87%
S&P 500 (^GSPC)
13.73%
1-Year Return
PB8.MU
57.22%
S&P 500 (^GSPC)
1.42%
3-Year Return
PB8.MU
8.93%
S&P 500 (^GSPC)
10.72%
5-Year Return
PB8.MU
7.73%
S&P 500 (^GSPC)
103.89%
Compare To: PB8.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
17.95
-4.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Mkt Cap undefined -
Industry -
4.5200
-6.42%
Mkt Cap 245.603M
Industry Drug Manufacturers—Specialty & Generic
13.80
-7.07%
Mkt Cap 17.295B
Industry Drug Manufacturers—Specialty & Generic
Statistics: PB8.MU
View MoreValuation Measures
As of 4/4/2025
Market Cap
703.85M
Enterprise Value
1.36B
Trailing P/E
41.30
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
3.25
Enterprise Value/Revenue
1.36
Enterprise Value/EBITDA
14.80
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--